Par Pharmaceutical, Inc. et al. vs. Novartis AG
Explore the PTAB proceeding IPR2016-00078 filed by Par Pharmaceutical, Inc. et al. on 2015-10-26. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-00078
Filing Date
2015-10-26
Accorded Filing Date
2015-10-26
Institution Decision Date
2016-04-28
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2016-04-28
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Par Pharmaceutical, Inc. et al.
Represented By
Brown, Danielet alPatent Owner / Respondent
Novartis AG
Represented By
Kallas, Nicholaset alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 (Biotechnology & Organic Chemistry)
Decisions Rendered
1 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 39030 | Jean Silveri | +1 617-871-5134 |
| 40232 | Timothy Witkowski | +1 617-301-1869 |
| 43228 | Peter Waibel | +1 862-778-7838 |
| 46473 | Emily Wu | +1 858-812-1539 |
| 46593 | Laurie Lawrence | +1 617-871-8584 |
| 48631 | Carol Fang | +1 650-467-2901 |
| 51681 | Mark Flanigan | +1 817-615-5080 |
| 53504 | Daniel Raymond | +1 858-812-1617 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| ๐ฌ๐ง United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| ๐ฌ๐ง United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → |
Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc.
Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc.